These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34650975)

  • 1. A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma.
    Lin C; Chen J; Su Z; Liu P; Liu Z; Zhu C; Xu D; Lin Z; Xu P; Liu G; Liu X
    Front Cell Dev Biol; 2021; 9():723103. PubMed ID: 34650975
    [No Abstract]   [Full Text] [Related]  

  • 2. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 4. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas.
    Liu P; Li Y; Zhang Y; Choi J; Zhang J; Shang G; Li B; Lin YJ; Saleh L; Zhang L; Yi L; Yu S; Lim M; Yang X
    Front Oncol; 2022; 12():708272. PubMed ID: 35646664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
    Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
    Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment.
    Li H; Wang G; Wang W; Pan J; Zhou H; Han X; Su L; Ma Z; Hou L; Xue X
    Front Oncol; 2021; 11():698278. PubMed ID: 34631528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
    Sun X; Liu X; Xia M; Shao Y; Zhang XD
    J Transl Med; 2019 May; 17(1):159. PubMed ID: 31097021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas.
    Chen S; Zhang S; Wang Z; Li J; Yuan Y; Li T; Zuo M; Feng W; Li W; Chen M; Liu Y
    Front Pharmacol; 2022; 13():1038272. PubMed ID: 36438805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
    Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
    J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
    [No Abstract]   [Full Text] [Related]  

  • 15. An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis.
    Wang X; Gao M; Ye J; Jiang Q; Yang Q; Zhang C; Wang S; Zhang J; Wang L; Wu J; Zhan H; Hou X; Han D; Zhao S
    Front Genet; 2020; 11():612037. PubMed ID: 33391355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma.
    Luo X; Wang Q; Tang H; Chen Y; Li X; Chen J; Zhang X; Li Y; Sun J; Han S
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676646
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas.
    Luo C; Liu Z; Ye W; Liu F
    Front Cell Dev Biol; 2021; 9():756005. PubMed ID: 34805164
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas.
    He Y; Zhang X; Zhang S; Zhang Y; Xie B; Huang M; Zhang J; Shen L; Long W; Liu Q
    Front Genet; 2023; 14():1120354. PubMed ID: 36845382
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.